| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1994 Oxford University Press
OTHER |
Characterization and expression of cDNA encoding coproporphyrinogen oxidase from a patient with hereditary coproporphyria
Tohoku University School of Medicine Sendai 98077 1National Institute of Public Health Tokyo 108 2Kansai Medical University Osaka 570, Japan 3The Rockefeller University New York, NY 10021, USA
*To whom correspondence should be addressed
Received June 6, 1994; Revised August 5, 1994; Accepted August 5, 1994
Hereditary coproporphyria (HCP) is an acute hepatic porphyria with autosomal dominant inheritance, but with a variable degree of clinical expression. Molecular cloning, sequencing and expression of the defective gene for coproporphyrinogen oxidase (CPO) in a patient with HCP were carried out. Enzyme assays revealed that CPO activity in EBV-transformed lymphoblastoid cells from the proband and one of her sisters was
50% of normal. Nucleotide sequence analysis of CPO cDNAs isolated from the proband's cells demonstrated three base substitutions, and three accompanying amino acid substitutions. An A514
C transition causing a Asn172
His substitution occurred in one allele, while two other transitions, G265
A and G580
A, caused Gly89
Ser and Val194
Ile substitutions, respectively, in the other allele. The A514
C and the G580
A transitions are known genetic polymorphisms. Transfection of CPO cDNA into Escherichia coli demonstrated that cDNA with the G265
A transition produced a protein with less than 5% of normal enzyme activity. These findings indicate that the G265
A transition, involving the highly conserved glycine residue at the 89th position, is responsible for the CPO defect in the patient and accounts for the partial deficiency of CPO activity in this pedigree.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Hanaoka, S. Katayama, I. B. Dawid, and A. Kawahara Characterization of the heme synthesis enzyme coproporphyrinogen oxidase (CPO) in zebrafish erythrogenesis Genes Cells, March 1, 2006; 11(3): 293 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schmitt, L. Gouya, E. Malonova, J. Lamoril, J.-M. Camadro, M. Flamme, C. Rose, S. Lyoumi, V. Da Silva, C. Boileau, et al. Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria Hum. Mol. Genet., October 15, 2005; 14(20): 3089 - 3098. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Phillips, F. G. Whitby, C. A. Warby, P. Labbe, C. Yang, J. W. Pflugrath, J. D. Ferrara, H. Robinson, J. P. Kushner, and C. P. Hill Crystal Structure of the Oxygen-dependant Coproporphyrinogen Oxidase (Hem13p) of Saccharomyces cerevisiae J. Biol. Chem., September 10, 2004; 279(37): 38960 - 38968. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Doss, A. Kuhnel, and U. Gross ALCOHOL AND PORPHYRIN METABOLISM Alcohol Alcohol., March 1, 2000; 35(2): 109 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lamoril, H. Puy, L. Gouya, R. Rosipal, V. Da Silva, B. Grandchamp, T. Foint, B. Bader-Meunier, J.P. Dommergues, J.C. Deybach, et al. Neonatal Hemolytic Anemia Due to Inherited Harderoporphyria: Clinical Characteristics and Molecular Basis Blood, February 15, 1998; 91(4): 1453 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Medlock and H. A. Dailey Human Coproporphyrinogen Oxidase Is Not a Metalloprotein J. Biol. Chem., December 20, 1996; 271(51): 32507 - 32510. [Abstract] [Full Text] [PDF] |
||||




